全球 DNA 診斷市場研究報告 - 2023 年至 2030 年產業分析、規模、佔有率、成長、趨勢和預測

全球 DNA 診斷市場需求預計將從 2022 年的 112.1 億美元增至 2030 年的近 169.3 億美元，2023-2030 年研究期間複合CAGR為 5.29%。

DNA 診斷，也稱為基因測試或DNA 測試，是一套實驗室技術和程序，用於分析個體的DNA（脫氧核糖核酸），以獲取有關其基因組成、遺傳傾向、血統和潛在遺傳疾病或狀況的訊息。它提供了有關個人基因組成的寶貴見解，幫助醫療保健專業人員就疾病診斷、風險評估和治療做出明智的決定。

市場動態：

基因組研究的進步加深了對遺傳與疾病和病症之間聯繫的理解，刺激了對 DNA 診斷的需求，以評估遺傳傾向和個人化醫療保健。人們對基因檢測對健康風險評估、血統追蹤和個人化醫療的潛在益處的認知不斷提高，大大增加了需求。精準醫學的概念是根據個別基因圖譜客製化醫療干預措施，在很大程度上依賴 DNA 診斷。此外，癌症盛行率的上升以及遺傳訊息在癌症治療決策中的整合推動了市場的發展，基因檢測被用來識別突變並指導治療。藥物基因組學、產前和新生兒篩檢、直接面對消費者的測試、監管支援和技術進步都促進了市場的成長。此外，生物技術和製藥公司的標靶治療、個人化醫療保健以及研究投資正在擴大 DNA 診斷的效用。隨著人口老化和個人化醫療保健趨勢的持續存在，DNA 診斷市場預計將繼續發展，提供更廣泛的測試和應用。然而，圍繞基因資料的倫理和隱私問題仍將是市場發展的重要面向。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球 DNA 診斷市場的各個細分市場進行了包容性評估。 DNA 診斷產業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲 DNA 診斷市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。 DNA診斷市場的主要參與者包括GE Healthcare、Abbott、Beckman Coulter Inc.、Bio-Rad Laboratories, Inc.、Thermo Fisher Scientific Inc.、Illumina Inc.、Cepheid、Hologic Inc.、Siemens Healthcare GmbH、F. Hoffmann - La Roche、QIAGEN、Agilent Technologies Inc。本部分包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概覽、合作、新產品開發、新產品發布，以及其他進展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

• 報告說明
  • 客觀的
  • 目標受眾
  • 獨特的銷售主張 (USP) 和產品
• 研究範圍
• 研究方法論
  • 市場研究過程
  • 市場研究方法論

第 2 章：執行摘要

• 市場亮點
• 全球市場概況

第 3 章：DNA 診斷 - 產業分析

• 簡介 - 市場動態
• 市場促進因素
• 市場限制
• 機會
• 產業動態
• 波特五力分析
• 市場吸引力分析
  • 按技術分類的市場吸引力分析
  • 市場吸引力分析：依應用分類
  • 市場吸引力分析：按地區

第 4 章：價值鏈分析

• 價值鏈分析
• 原料分析
  • 原料清單
  • 原料廠商清單
  • 主要原物料價格走勢
• 潛在買家名單
• 行銷管道
  • 直效行銷
  • 間接行銷
  • 行銷通路發展趨勢

第 5 章：全球 DNA 診斷市場分析：依技術分類

• 依技術概述
• 歷史和預測數據
• 依技術分析
• 基於微陣列的診斷
• 基於 PCR 的診斷
• 原位雜合技術診斷
• NGS DNA診斷

第 6 章：全球 DNA 診斷市場分析：依應用分類

• 概述：按應用
• 歷史和預測數據
• 分析：按應用
• 癌症遺傳學測試
• 傳染病DNA檢測（HBV診斷、HCV診斷、HIV診斷、結核病診斷、CT/NG診斷、HPV診斷、MRSA診斷、其他）
• 新生兒基因篩檢
• 植入前和生殖診斷
• 非傳染性疾病 DNA 檢測（心血管疾病、中樞神經系統和三七總皂苷相關、骨骼、結締、外胚層和真皮 DNA 檢測、肺、腎、肝臟和 GT 相關、感覺疾病）
• 產前 DNA 帶因者篩檢
• 藥物基因體學/藥物代謝
• 血液學與免疫學/身分診斷與法醫學
• 其他

第 7 章：全球 DNA 診斷市場分析：依地理位置

• 區域展望
• 介紹
• 北美銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 北美按細分市場銷售分析
  • 北美按國家銷售分析
  • 美國銷售分析
  • 加拿大銷售分析
  • 墨西哥銷售分析
• 歐洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 歐洲按細分市場銷售分析
  • 歐洲按國家銷售分析
  • 英國銷售分析
  • 法國銷售分析
  • 德國銷售分析
  • 義大利銷售分析
  • 俄羅斯銷售分析
  • 歐洲其他地區銷售分析
• 亞太地區銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 亞太地區按細分市場銷售分析
  • 亞太地區國家/地區銷售分析
  • 中國銷售分析
  • 印度銷售分析
  • 日本銷售分析
  • 韓國銷售分析
  • 澳洲銷售分析
  • 東南亞銷售分析
  • 亞太地區其他地區銷售分析
• 拉丁美洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 拉丁美洲按細分市場銷售分析
  • 拉丁美洲按國家銷售分析
  • 巴西銷售分析
  • 阿根廷銷售分析
  • 秘魯銷售分析
  • 智利銷售分析
  • 拉丁美洲其他地區銷售分析
• 中東和非洲銷售分析
  • 概覽、歷史與預測資料銷售分析
  • 中東和非洲按細分市場銷售分析
  • 中東和非洲國家銷售分析
  • 沙烏地阿拉伯銷售分析
  • 阿拉伯聯合大公國銷售分析
  • 以色列銷售分析
  • 南非銷售分析
  • 中東其他地區和非洲銷售分析

第 8 章：DNA 診斷公司的競爭格局

• DNA診斷市場競爭
• 夥伴關係/協作/協議
• 併購
• 新產品發布
• 其他發展

第 9 章：公司簡介

• 頂級公司市佔率分析
• 市場集中度
• GE Healthcare
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Abbott
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Beckman Coulter Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Bio-Rad Laboratories Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Thermo Fisher Scientific Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Illumina Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Cepheid
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Hologic Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Siemens Healthcare GmbH
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• F. Hoffmann-La Roche
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• QIAGEN
• 公司簡介
• 公司收入
• 產品
• 最近的發展
• Agilent Technologies Inc.
• 公司簡介
• 公司收入
• 產品
• 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

The global demand for DNA Diagnostics Market is presumed to reach the market size of nearly USD 16.93 BN by 2030 from USD 11.21 BN in 2022 with a CAGR of 5.29% under the study period 2023 - 2030.

DNA diagnostics, also known as genetic testing or DNA testing, is a set of laboratory techniques and procedures used to analyze an individual's DNA (deoxyribonucleic acid) to gain information about their genetic makeup, genetic predispositions, ancestry, and potential genetic disorders or conditions. It provides valuable insights into an individual's genetic composition, helping healthcare professionals make informed decisions about disease diagnosis, risk assessment, and treatment.

MARKET DYNAMICS:

Advancements in genomic research have deepened the understanding of genetic links to diseases and conditions, spurring the demand for DNA diagnostics to assess genetic predispositions and personalize healthcare. This surge in awareness among individuals about genetic testing's potential benefits for health risk assessment, ancestry tracing, and personalized medicine has significantly boosted demand. The concept of precision medicine, which customizes healthcare interventions based on individual genetic profiles, relies heavily on DNA diagnostics. Additionally, the rising prevalence of cancer and the integration of genetic information in cancer treatment decisions have fueled the market, with genetic testing being used to identify mutations and guide therapy. Pharmacogenomics, prenatal and newborn screening, direct-to-consumer testing, regulatory support, and advancements in technology have all contributed to the market's growth. Furthermore, targeted therapies, healthcare personalization, and research investments by biotech and pharmaceutical companies are expanding the utility of DNA diagnostics. As the aging population and the trend toward personalized healthcare persist, the DNA diagnostics market is expected to continue evolving, offering a wider range of tests and applications. However, ethical and privacy concerns surrounding genetic data will remain a significant aspect of the market's development.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dna diagnostics. The growth and trends of dna diagnostics industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the dna diagnostics market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Technology

• Microarrays-Based Diagnostics
• PCR-Based Diagnostics
• In-Situ Hybridization Diagnostics
• NGS DNA Diagnosis

By Application

• Cancer Genetics Tests
• Infectious Diseases Dna Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others)
• Newborn Genetic Screening
• Preimplantation & Reproductive Diagnosis
• Non-Infectious Diseases Dna Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases)
• Prenatal DNA Carrier Screening
• Pharmacogenomics/Drug Metabolism
• Hematology & Immunology/Identity Diagnostics & Forensics
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the DNA Diagnostics market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the DNA Diagnostics market include GE Healthcare, Abbott, Beckman Coulter Inc., Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., Illumina Inc., Cepheid, Hologic Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche, QIAGEN, Agilent Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . DNA DIAGNOSTICS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Technology
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY TECHNOLOGY

• 5.1 Overview by Technology
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Technology
• 5.4 Microarrays-based Diagnostics Historic and Forecast Sales by Regions
• 5.5 PCR-based Diagnostics Historic and Forecast Sales by Regions
• 5.6 In-situ Hybridization Diagnostics Historic and Forecast Sales by Regions
• 5.7 NGS DNA Diagnosis Historic and Forecast Sales by Regions

6 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Cancer Genetics Tests Historic and Forecast Sales by Regions
• 6.5 Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Historic and Forecast Sales by Regions
• 6.6 Newborn Genetic Screening Historic and Forecast Sales by Regions
• 6.7 Preimplantation & Reproductive Diagnosis Historic and Forecast Sales by Regions
• 6.8 Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Historic and Forecast Sales by Regions
• 6.9 Prenatal DNA Carrier Screening Historic and Forecast Sales by Regions
• 6.10. Pharmacogenomics/Drug Metabolism Historic and Forecast Sales by Regions
• 6.11 Hematology & Immunology/Identity Diagnostics & Forensics Historic and Forecast Sales by Regions
• 6.12 Others Historic and Forecast Sales by Regions

7 . GLOBAL DNA DIAGNOSTICS MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2. North America By Segment Sales Analysis
  • 7.3.3. North America By Country Sales Analysis
  • 7.3.4. United State Sales Analysis
  • 7.3.5. Canada Sales Analysis
  • 7.3.6. Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2. Europe by Segment Sales Analysis
  • 7.4.3. Europe by Country Sales Analysis
  • 7.4.4. United Kingdom Sales Analysis
  • 7.4.5. France Sales Analysis
  • 7.4.6. Germany Sales Analysis
  • 7.4.7. Italy Sales Analysis
  • 7.4.8. Russia Sales Analysis
  • 7.4.9. Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2. Asia Pacific by Segment Sales Analysis
  • 7.5.3. Asia Pacific by Country Sales Analysis
  • 7.5.4. China Sales Analysis
  • 7.5.5. India Sales Analysis
  • 7.5.6. Japan Sales Analysis
  • 7.5.7. South Korea Sales Analysis
  • 7.5.8. Australia Sales Analysis
  • 7.5.9. South East Asia Sales Analysis
  • 7.5.10. Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2. Latin America by Segment Sales Analysis
  • 7.6.3. Latin America by Country Sales Analysis
  • 7.6.4. Brazil Sales Analysis
  • 7.6.5. Argentina Sales Analysis
  • 7.6.6. Peru Sales Analysis
  • 7.6.7. Chile Sales Analysis
  • 7.6.8. Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2. Middle East & Africa by Segment Sales Analysis
  • 7.7.3. Middle East & Africa by Country Sales Analysis
  • 7.7.4. Saudi Arabia Sales Analysis
  • 7.7.5. UAE Sales Analysis
  • 7.7.6. Israel Sales Analysis
  • 7.7.7. South Africa Sales Analysis
  • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DNA DIAGNOSTICS COMPANIES

• 8.1. Dna Diagnostics Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9 . COMPANY PROFILES OF DNA DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. GE Healthcare
  • 9.3.1. Company Overview
  • 9.3.2. Company Revenue
  • 9.3.3. Products
  • 9.3.4. Recent Developments
• 9.4. Abbott
  • 9.4.1. Company Overview
  • 9.4.2. Company Revenue
  • 9.4.3. Products
  • 9.4.4. Recent Developments
• 9.5. Beckman Coulter Inc.
  • 9.5.1. Company Overview
  • 9.5.2. Company Revenue
  • 9.5.3. Products
  • 9.5.4. Recent Developments
• 9.6. Bio-Rad Laboratories Inc.
  • 9.6.1. Company Overview
  • 9.6.2. Company Revenue
  • 9.6.3. Products
  • 9.6.4. Recent Developments
• 9.7. Thermo Fisher Scientific Inc.
  • 9.7.1. Company Overview
  • 9.7.2. Company Revenue
  • 9.7.3. Products
  • 9.7.4. Recent Developments
• 9.8. Illumina Inc.
  • 9.8.1. Company Overview
  • 9.8.2. Company Revenue
  • 9.8.3. Products
  • 9.8.4. Recent Developments
• 9.9. Cepheid
  • 9.9.1. Company Overview
  • 9.9.2. Company Revenue
  • 9.9.3. Products
  • 9.9.4. Recent Developments
• 9.10. Hologic Inc.
  • 9.10.1. Company Overview
  • 9.10.2. Company Revenue
  • 9.10.3. Products
  • 9.10.4. Recent Developments
• 9.11. Siemens Healthcare GmbH
  • 9.11.1. Company Overview
  • 9.11.2. Company Revenue
  • 9.11.3. Products
  • 9.11.4. Recent Developments
• 9.12. F. Hoffmann-La Roche
  • 9.12.1. Company Overview
  • 9.12.2. Company Revenue
  • 9.12.3. Products
  • 9.12.4. Recent Developments
• 9.13. QIAGEN
  • 9.13.1. Company Overview
  • 9.13.2. Company Revenue
  • 9.13.3. Products
  • 9.13.4. Recent Developments
• 9.14. Agilent Technologies Inc.
  • 9.14.1. Company Overview
  • 9.14.2. Company Revenue
  • 9.14.3. Products
  • 9.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Technology (USD MN)
• Microarrays-based Diagnostics Market Sales by Geography (USD MN)
• PCR-based Diagnostics Market Sales by Geography (USD MN)
• In-situ Hybridization Diagnostics Market Sales by Geography (USD MN)
• NGS DNA Diagnosis Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Cancer Genetics Tests Market Sales by Geography (USD MN)
• Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Market Sales by Geography (USD MN)
• Newborn Genetic Screening Market Sales by Geography (USD MN)
• Preimplantation & Reproductive Diagnosis Market Sales by Geography (USD MN)
• Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Market Sales by Geography (USD MN)
• Prenatal DNA Carrier Screening Market Sales by Geography (USD MN)
• Pharmacogenomics/Drug Metabolism Market Sales by Geography (USD MN)
• Hematology & Immunology/Identity Diagnostics & Forensics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Dna Diagnostics Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Dna Diagnostics Report
• Market Research Process
• Market Research Methodology
• Global Dna Diagnostics Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Technology
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Technology (USD MN)
• Microarrays-based Diagnostics Market Sales by Geography (USD MN)
• PCR-based Diagnostics Market Sales by Geography (USD MN)
• In-situ Hybridization Diagnostics Market Sales by Geography (USD MN)
• NGS DNA Diagnosis Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Cancer Genetics Tests Market Sales by Geography (USD MN)
• Infectious Diseases DNA Testing (HBV Diagnostic, HCV Diagnostic, HIV Diagnostic, TB Diagnostic, CT/NG Diagnostic, HPV Diagnostic, MRSA Diagnostic, Others) Market Sales by Geography (USD MN)
• Newborn Genetic Screening Market Sales by Geography (USD MN)
• Preimplantation & Reproductive Diagnosis Market Sales by Geography (USD MN)
• Non-Infectious Diseases DNA Testing (Cardiovascular Diseases, CNS & PNS Related, Skeletal, Connective, Ectodermal & Dermal DNA Testing, Lung, Kidney, Liver & GT Related, Sensory Diseases) Market Sales by Geography (USD MN)
• Prenatal DNA Carrier Screening Market Sales by Geography (USD MN)
• Pharmacogenomics/Drug Metabolism Market Sales by Geography (USD MN)
• Hematology & Immunology/Identity Diagnostics & Forensics Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.